Proposal to make Dovonex Psoriasis Ointment available from Pharmacies
We are considering making Dovonex Psoriasis 50 microgram/g Ointment available to buy from pharmacies. We always want to involve the public and healthcare professionals in decisions that affect them. We want to know what you think about this change.
Detail
We want to know what you think
- Dovonex Psoriasis 50 microgram/g Ointment is used to treat mild to moderate plaque psoriasis which has been previously diagnosed by a doctor in adults aged 18 years and over.
- Calcipotriol is only at the moment available on prescription (known as Dovonex Ointment).
- We propose to make it available in pharmacies without prescription.
- The Commission on Human Medicines has advised that this product can be available as a pharmacy medicine.
- We want to know what you think about this change.
Please tell us your views using the attached document.
This consultation closes at 5pm on 20 April 2017
Documents
Dovonex Psoriasis Ointment public consultationapplication/pdfDovonex Psoriasis Ointment response documentapplication/mswordDovonex Psoriasis Ointment Public Assessment Reportapplication/pdfDispensing Doctor’s Association (DDA) responseapplication/pdfBritish Association of Dermatologists (BAD) responseapplication/pdfPsoriasis and Psoriatic Arthritis Association (PAPAA) responseapplication/pdfNational Pharmacy Association (NPA) responseapplication/pdfProprietary Association of Great Britain (PAGB) responseapplication/pdfRoyal Pharmaceutical Society (RPS) responseapplication/pdfDermatology Pharmacist responseapplication/pdfPatient responseapplication/pdfPatient 3 responseapplication/pdfPatient 2 responseapplication/pdf